PROVIDER PROFILE · NPI 1558680959

Daniel Chevy

PRACTICENANCY N JOHNSON LLCSee all providers at this practice →

Internal MedicineKamuela, HII

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

2,938

Beneficiaries

—

Total drug cost

$152K

Distinct drugs

Brand share

16.4%

Top prescribed drugs

Levothyroxine Sodium197 claims

Atorvastatin Calcium172 claims

Lisinopril164 claims

Amlodipine Besylate143 claims

Losartan Potassium121 claims

QUALITY · MIPS · 2024

Final MIPS score

74.0

Quality

59.8

Cost

54.6

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

-0.11%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Daniel Chevy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Daniel Miner Diagnostic Radiology · Nashua, NH	23	64
NPI 1386727840	22	77
Matthew Levine Diagnostic Radiology · Derry, NH	20	53
Salvatore Vella Internal Medicine · Nashua, NH	18	61
Robert Carbonneau Diagnostic Radiology · Nashua, NH	16	63
HOME HEALTH & HOSPICE CARE	14	46
Christopher Pyne Interventional Cardiology · Burlington, MA	14	51
Benjamin Faitelson Diagnostic Radiology · Derry, NH	12	29
ST JOSEPH HOSPITAL OF NASHUA NH	12	30
WEISS, GERRI	11	26

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history